The global cell counting market is estimated to have a substantial growth potential, with revenues expected to increase from $10.4 billion in 2020 to $14.5 billion by 2025, driven by factors such as increased funding for cell-based research, rising disease incidences, and advancements in technology.
Summary
The global cell counting market was valued at $10.4 billion in 2020 and is projected to reach $14.5 billion by 2025, with a compound annual growth rate (CAGR) of 6.7%.
Factors fueling market growth include increased funding for cell-based research, a rising incidence of chronic and infectious diseases, growth in the biotechnology and biopharmaceutical industries, advancements in solutions and image analysis, and increased use of high-throughput flow cytometry and automated hematology analyzers.
The medical application segment is expected to grow at the highest CAGR, with government initiatives in stem cell research and widespread usage of cell counting in research driving growth.
Hospitals and diagnostic…